GNBT Generex Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GNBT Generex

GNBT 0.00

Jan 27 3:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ACAN who wrote (270)	12/2/2008 2:52:32 PM
From: MJ	Read Replies (1) of 310

This also may be coming into play as this payment is now due----- biz.yahoo.com Perhaps by paying cash for the portion of the credit just due rather than giving stock to the creditor-----they are keeping control over the actual stock and ultimately the company. "Generex Biotechnology to Make Convertible Debenture Payment in Cash Wednesday November 12, 8:00 am ET Company Foregoes Issuing Equity at Current Level WORCESTER, Mass., Nov. 12, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM:GNBT - News) (http://www.generex.com) announced today that it intends to make the next payment, due on December 1, 2008, under its Senior Secured Convertible Notes in cash. The aggregate amount of that payment will be $1,376,666.66."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next